{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T20:52:57Z","timestamp":1775940777660,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":1205,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1093\/ndt\/gft203","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T00:33:57Z","timestamp":1371774837000},"page":"2383-2392","source":"Crossref","is-referenced-by-count":57,"title":["A comparison of calcium acetate\/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study"],"prefix":"10.1093","volume":"28","author":[{"given":"Adrian","family":"Covic","sequence":"first","affiliation":[]},{"given":"Jutta","family":"Passlick-Deetjen","sequence":"additional","affiliation":[]},{"given":"Miroslaw","family":"Kroczak","sequence":"additional","affiliation":[]},{"given":"Beatrix","family":"B\u00fcschges-Seraphin","sequence":"additional","affiliation":[]},{"given":"Adrian","family":"Ghenu","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Ponce","sequence":"additional","affiliation":[]},{"given":"Barbara","family":"Marzell","sequence":"additional","affiliation":[]},{"given":"Angel L.M.","family":"de Francisco","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2013,6,19]]},"reference":[{"key":"key\n\t\t\t\t20170518091752_GFT203C1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518091752_GFT203C2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/ndt\/gfn613","article-title":"Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease","volume":"24","author":"Covic","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5414\/CNP71021","article-title":"Efficacy of hyperphosphatemia control in the progression of chronic renal failure and the prevalence of cardiovascular calcification","volume":"71","author":"Lezaic","year":"2009","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2215\/CJN.00420108","article-title":"Serum phosphate levels and risk of infection in incident dialysis patients","volume":"3","author":"Plantinga","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518091752_GFT203C6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2008.05.020","article-title":"Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the hemodialysis (HEMO) study","volume":"52","author":"Wald","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518091752_GFT203C7","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1093\/ndt\/gfq292","article-title":"Evaluation of calcium acetate\/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability","volume":"25","author":"de Francisco","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2215\/CJN.08241109","article-title":"Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism","volume":"5","author":"Evenepoel","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C9","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5301\/jn.5000003","article-title":"What would we like to know, and what do we not know about fibroblast growth factor 23?","volume":"24","author":"Cozzolino","year":"2011","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518091752_GFT203C12","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170518091752_GFT203C13","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C14","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ndt\/gfp784","article-title":"The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?","volume":"25","author":"Larsson","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.2009.466","article-title":"FGF23-parathyroid interaction: implications in chronic kidney disease","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518091752_GFT203C16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C17","first-page":"619","article-title":"New insights into the role of fibroblast growth factor 23 in chronic kidney disease","volume":"23","author":"Nakai","year":"2010","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C18","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2215\/CJN.10711011","article-title":"FGF23 beyond mineral metabolism: a bridge to cardiovascular disease","volume":"6","author":"Larsson","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C19","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C20","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/ndt\/gfs050","article-title":"FGF23 and PTH\u2014double agents at the heart of CKD","volume":"27","author":"Silver","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C21","doi-asserted-by":"crossref","first-page":"c74","DOI":"10.1159\/000319650","article-title":"Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate","volume":"117","author":"Cancela","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170518091752_GFT203C22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD\u2013MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MNH.0b013e3281ca6ffd","article-title":"Emerging role of fibroblast growth factor 23 in a bone\u2013kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization","volume":"16","author":"Liu","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t20170518091752_GFT203C25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C26","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000086347","article-title":"Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism","volume":"101","author":"Nishi","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170518091752_GFT203C27","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","article-title":"Calcium deficiency reduces circulating levels of FGF23","volume":"23","author":"Rodriguez-Ortiz","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C28","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1210\/jc.2010-1277","article-title":"Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD","volume":"96","author":"Wetmore","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170518091752_GFT203C29","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ndt\/gfr384","article-title":"Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism","volume":"27","author":"Koizumi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/ndt\/11.6.1065","article-title":"Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients","volume":"11","author":"Couttenye","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Ure\u00f1a","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C32","doi-asserted-by":"crossref","first-page":"c122","DOI":"10.1159\/000086682","article-title":"Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients\u2014any advantage?","volume":"101","author":"Jorge","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170518091752_GFT203C33","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.V9101845","article-title":"High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro","volume":"9","author":"Almaden","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ndt\/gfp616","article-title":"Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate","volume":"25","author":"Canalejo","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C35","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification\u2013results from the BRiC study","volume":"110","author":"Barreto","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170518091752_GFT203C36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2169\/internalmedicine.46.6338","article-title":"Effect of sevelamer hydrochloride on markers of bone turnover in Japanese dialysis patients with low biointact PTH levels","volume":"46","author":"Iwata","year":"2007","journal-title":"Intern Med"},{"key":"key\n\t\t\t\t20170518091752_GFT203C37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/08860220600925388","article-title":"A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients","volume":"28","author":"Liu","year":"2006","journal-title":"Ren Fail"},{"key":"key\n\t\t\t\t20170518091752_GFT203C38","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00467-009-1143-8","article-title":"Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols","volume":"24","author":"Wesseling-Perry","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2008.248","article-title":"High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death","volume":"74","author":"Blayney","year":"2008","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518091752_GFT203C40","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00774-007-0785-5","article-title":"Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients","volume":"26","author":"Doumouchtsis","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"key\n\t\t\t\t20170518091752_GFT203C42","doi-asserted-by":"crossref","first-page":"c375","DOI":"10.1159\/000323669","article-title":"Relationship between biochemical markers and radial cortical bone changes in hemodialysis patients","volume":"118","author":"Fujimori","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170518091752_GFT203C43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","article-title":"Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients","volume":"82","author":"Shidara","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t20170518091752_GFT203C44","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091752_GFT203C45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jbmr.5650080112","article-title":"Physicochemical effects of acidosis on bone calcium flux and surface ion composition","volume":"8","author":"Bushinsky","year":"1993","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20170518091752_GFT203C46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1172\/JCI114729","article-title":"Acute metabolic acidosis enhances circulating parathyroid hormone, which contributes to the renal response against acidosis in the rat","volume":"86","author":"Bichara","year":"1990","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170518091752_GFT203C47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1525-139X.2008.00530.x","article-title":"Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis","volume":"22","author":"Navarro-Gonz\u00e1lez","year":"2009","journal-title":"Semin Dial"},{"key":"key\n\t\t\t\t20170518091752_GFT203C48","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000276665","article-title":"Magnesium in chronic kidney disease: challenges and opportunities","volume":"29","author":"Kanbay","year":"2010","journal-title":"Blood Purif"},{"key":"key\n\t\t\t\t20170518091752_GFT203C49","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1093\/ndt\/gfs126","article-title":"Hypomagnesaemia, the kidney and the vessels","volume":"27","author":"Van Laecke","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091752_GFT203C50","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/clinchem\/45.9.1548","article-title":"Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients","volume":"45","author":"D'Haese","year":"1999","journal-title":"Clin Chem"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/28\/9\/2383\/17171578\/gft203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T23:47:19Z","timestamp":1645832839000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gft203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,19]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,6,19]]},"published-print":{"date-parts":[[2013,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gft203","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,19]]}}}